SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001654954-19-005037
Filing Date
2019-04-30
Accepted
2019-04-30 16:35:25
Documents
5
Effectiveness Date
2019-04-30

Document Format Files

Seq Description Document Type Size
1 DEFA14A finalregisterednoticecard.htm DEFA14A 14576
2 IMAGE finalntc2019pg3.jpg GRAPHIC 56167
3 IMAGE finalntc2019pg4.jpg GRAPHIC 21704
4 IMAGE finalntc2019tgtherapeutic.jpg GRAPHIC 132603
5 IMAGE finalntc2019tgtherapeutic000.jpg GRAPHIC 80968
  Complete submission text file 0001654954-19-005037.txt   396180
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32639 | Film No.: 19782356
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1